Lead party: Y Combinator Management, LLC (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Eden Care Medical
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Ordinary Shares (Equity), Simple Agreement for Future Equity (SAFE) (Equity) · Deal amount: US$500,000 · Equity stake: 0.07% · Implied EV: US$7.1m
Lead investor/buyer: Y Combinator Management, LLC · Investors/buyers: Y Combinator Management, LLC
Legal advisers: not identified in the source record.
Source: announced 12 July 2023. Original announcement: techmoran.com.


